Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00588614 · ClinicalTrials.gov registry record
High Risk Screening Breast MR Using a Rapid Imaging Exam
A clinical trial, sponsored by Mayo Clinic.
- Completed
- Registry status
- 140
- Enrollment target
NCT00588614: Completed study, sponsored by Mayo Clinic.
NCT00588614 is a clinical trial that has completed, run by Mayo Clinic. The registered enrollment target is 140 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00588614 has completed, sponsored by Mayo Clinic.
- COMPLETED
- Registry status
- 140 participants
- Enrollment target
Study Summary
This study is being done to find out if breast cancer detection will be improved using a short MRI (magnetic resonance imaging) scan, in addition to mammography, in patients who are at an increased risk of developing breast cancer.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 140 participants |
| Start Date | 2006-04 |
| Est. Completion | 2011-02 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00588614
The ClinicalTrials.gov registry entry for NCT00588614 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 140 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Mayo Clinic, which has 2,844 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT00588614 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00588614 about?
NCT00588614 is a clinical study titled "High Risk Screening Breast MR Using a Rapid Imaging Exam". This study is being done to find out if breast cancer detection will be improved using a short MRI (magnetic resonance imaging) scan, in addition to mammography, in patients who are at an increased risk of developing breast cancer.
What is the current status of trial NCT00588614?
This trial is currently completed. The enrollment target is 140 participants. The study started on 2006-04. Estimated completion is 2011-02.
Who is sponsoring clinical trial NCT00588614?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.